Abeona Therapeutics (ABEO) EBITDA Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
Abeona Therapeutics (ABEO) EBITDA Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | 557,803.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 557,803.00 |
| Jun 30, 2023 | 49,926.00 |
| Dec 31, 2018 | 95,257.00 |
| Sep 30, 2018 | 145,858.00 |
| Jun 30, 2018 | -66,024.00 |
| Mar 31, 2018 | 82,900.00 |
| Dec 31, 2017 | -355,521.00 |
| Sep 30, 2017 | 36,355.00 |
| Jun 30, 2017 | -75,155.00 |
| Mar 31, 2017 | -21,958.00 |
| Dec 31, 2016 | 63,025.00 |
| Sep 30, 2016 | -64,915.00 |
| Jun 30, 2016 | -167,438.00 |
| Mar 31, 2016 | -184,531.00 |
| Dec 31, 2015 | -270,880.00 |
| Sep 30, 2015 | -189,459.00 |
| Jun 30, 2015 | -117,886.00 |
| Mar 31, 2015 | -13,751.00 |
| Dec 31, 2014 | 506,197.00 |
| Sep 30, 2014 | 10,003.00 |